Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (20) 20
science & technology (20) 20
humans (18) 18
cardiac & cardiovascular systems (17) 17
cardiovascular system & cardiology (17) 17
male (16) 16
female (15) 15
middle aged (15) 15
treatment outcome (14) 14
abridged index medicus (12) 12
aged (10) 10
heart attack (9) 9
myocardial infarction - drug therapy (9) 9
secondary prevention (9) 9
heart attacks (7) 7
myocardial infarction (7) 7
myocardial infarction - diagnosis (7) 7
cardiology (6) 6
care and treatment (6) 6
coronary heart disease (6) 6
heart (6) 6
myocardial infarction - mortality (6) 6
stroke (6) 6
ticagrelor (6) 6
analysis (5) 5
biological and medical sciences (5) 5
double-blind method (5) 5
electrocardiography (5) 5
hemorrhage - chemically induced (5) 5
medical sciences (5) 5
myocardial infarction - therapy (5) 5
prevention (5) 5
risk factors (5) 5
stroke - prevention & control (5) 5
transluminal angioplasty (5) 5
adenosine - analogs & derivatives (4) 4
cardiac patients (4) 4
cardiovascular disease (4) 4
clinical medicine (4) 4
clinical trials (4) 4
coronary angiography (4) 4
drug administration schedule (4) 4
klinisk medicin (4) 4
myocardial infarction - prevention & control (4) 4
patients (4) 4
percutaneous coronary intervention (4) 4
peripheral vascular disease (4) 4
pyridines - therapeutic use (4) 4
risk (4) 4
safety (4) 4
time factors (4) 4
[sdv]life sciences [q-bio] (3) 3
adenosine - administration & dosage (3) 3
angioplasty, balloon, coronary (3) 3
antiplatelet therapy (3) 3
atrial fibrillation (3) 3
cardiac and cardiovascular systems (3) 3
cardiology. vascular system (3) 3
cardiovascular diseases (3) 3
coronary artery disease (3) 3
coronary vessels (3) 3
dosage and administration (3) 3
follow-up studies (3) 3
infarction (3) 3
kardiologi (3) 3
lactones - therapeutic use (3) 3
life sciences (3) 3
mortality (3) 3
platelet aggregation inhibitors - therapeutic use (3) 3
polymer industry (3) 3
purinergic p2y receptor antagonists - administration & dosage (3) 3
randomization (3) 3
recurrence (3) 3
renal function (3) 3
secondary prevention - methods (3) 3
thrombolytic therapy (3) 3
acute coronary syndrome (2) 2
acute coronary syndromes (2) 2
adenosine - adverse effects (2) 2
adenosine - therapeutic use (2) 2
adult (2) 2
angioplasty (2) 2
anticoagulants (2) 2
apolipoproteins (2) 2
arrhythmias, cardiac - diagnosis (2) 2
arrhythmias, cardiac - etiology (2) 2
aspirin (2) 2
aspirin - administration & dosage (2) 2
atherosclerosis (2) 2
bleeding (2) 2
c-reactive protein (2) 2
cardiology and cardiovascular medicine (2) 2
cardiovascular (2) 2
cardiovascular system (2) 2
clinical outcomes (2) 2
coronary sinus (2) 2
coronary vessels - drug effects (2) 2
coronary vessels - surgery (2) 2
dabigatran dual therapy (2) 2
diabetes mellitus (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Effect of losmapimod on cardiovascular outcomes in patients hospitalized with acute myocardial infarction: A randomized clinical trial
by O'Donoghue, Michelle L and Glaser, Ruchira and Cavender, Matthew A and Aylward, Philip E and Bonaca, Marc P and Budaj, Andrzej and Davies, Richard Y and Dellborg, Mikael and Fox, Keith A. A and Gutierrez, Jorge Antonio T and Hamm, Christian and Kiss, Robert G and Kovar, František and Kuder, Julia F and Im, Kyung Ah and Lepore, John J and Lopez-Sendon, Jose L and Ophuis, Ton Oude and Parkhomenko, Alexandr and Shannon, Jennifer B and Spinar, Jindrich and Tanguay, Jean-Francois and Ruda, Mikhail and Steg, P. Gabriel and Theroux, Pierre and Wiviott, Stephen D and Laws, Ian and Sabatine, Marc S and Morrow, David A and LATITUDE-TIMI 60 Investigators
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 04/2016, Volume 315, Issue 15, pp. 1591 - 1599
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Recurrence | Myocardial Infarction - mortality | Humans | Middle Aged | Male | Secondary Prevention | Cyclopropanes - adverse effects | Protein Kinase Inhibitors - adverse effects | Cyclopropanes - therapeutic use | Pyridines - adverse effects | Treatment Failure | Female | C-Reactive Protein - analysis | Myocardial Infarction - enzymology | Pyridines - therapeutic use | Double-Blind Method | Drug Administration Schedule | Myocardial Ischemia - prevention & control | Hospitalization | Myocardial Revascularization | Algorithms | Myocardial Infarction - drug therapy | Protein Kinase Inhibitors - therapeutic use | p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors | Aged | Myocardial Ischemia - surgery | Patient safety | Clinical trials | Inhibitor drugs | Heart attacks | Clinical outcomes
Journal Article
Details down arrow
2. Full Text A multi-site coronary sampling study on CRP in non-STEMI: Novel insights into the inflammatory process in acute coronary syndromes
by Damen, Sander A.J and Cramer, Gilbert E and Dieker, Hendrik-Jan and Gehlmann, Helmut and Aengevaeren, Wim R.M and Oude Ophuis, Ton J.M and Fokkert, Marion J and Dikkeschei, Lambert D and Vroemen, Wim H.M and Verheugt, Freek W.A and Brouwer, Marc A and Suryapranata, Harry
Atherosclerosis, ISSN 0021-9150, 11/2018, Volume 278, pp. 117 - 123
NSTEMI | Inflammation | C-reactive protein | Coronary sinus | Cardiac & Cardiovascular Systems | Peripheral Vascular Disease | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology | Coronary heart disease | Cardiac patients | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54
by Bonaca, Marc P and Storey, Robert F and Theroux, Pierre and Steg, P. Gabriel and Bhatt, Deepak L and Cohen, Marc C and Im, KyungAh and Murphy, Sabina A and Magnani, Giulia and Ophuis, Ton Oude and Rudah, Mikhail and Parkhomenko, Alexander and Isaza, Daniel and Kamensky, Gabriel and Goudev, Assen and Montalescot, Gilles and Jensen, Eva C and Johanson, Per and Braunwald, Eugene and Sabatine, Marc S
Journal of the American College of Cardiology, ISSN 0735-1097, 09/2017, Volume 70, Issue 11, pp. 1368 - 1375
P2Y12 inhibition | cardiovascular death | secondary prevention | stroke | ischemic risk | myocardial infarction | P2Y | inhibition | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Myocardial Infarction - diagnosis | Myocardial Infarction - mortality | Purinergic P2Y Receptor Antagonists - administration & dosage | Survival Rate - trends | Follow-Up Studies | Global Health | Humans | Middle Aged | Male | Treatment Outcome | Adenosine - administration & dosage | Dose-Response Relationship, Drug | Myocardial Infarction - drug therapy | Time Factors | Adenosine - analogs & derivatives | Thrombolytic Therapy - methods | Electrocardiography | Cause of Death - trends | Female | Aged | Ticagrelor | Myocardial infarction | Cardiovascular system | Heart | Cerebral infarction | Anticoagulants | Aspirin | Stroke | Heart attacks | Effectiveness | Risk | Cardiovascular disease | Patients | Thrombolysis | Bleeding | Disease prevention | Prevention | Confidence intervals | Survival analysis | Randomization | Ischemia | Infarction | Safety | Health risk assessment | Drug dosages
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial
by de Winter, Robbert J and Katagiri, Yuki and Asano, Taku and Milewski, Krzysztof P and Lurz, Philipp and Buszman, Pawel and Jessurun, Gillian A J and Koch, Karel T and Troquay, Roland P T and Hamer, Bas J B and Ophuis, Ton Oude and Wöhrle, Jochen and Wyderka, Rafał and Cayla, Guillaume and Hofma, Sjoerd H and Levesque, Sébastien and Żurakowski, Aleksander and Fischer, Dieter and Kośmider, Maciej and Goube, Pascal and Arkenbout, E Karin and Noutsias, Michel and Ferrari, Markus W and Onuma, Yoshinobu and Wijns, William and Serruys, Patrick W
The Lancet (British edition), ISSN 0140-6736, 02/2018, Volume 391, Issue 10119, pp. 431 - 440
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Transluminal angioplasty | Product development | Polymer industry | Analysis | Surgical implants | Heart attacks | Angioplasty | Cyclin-dependent kinases | Clinical trials | Cardiovascular disease | Rapamycin | Chromium alloys | Patients | Thrombosis | Evidence-based medicine | Clinical outcomes | Coronary vessels | Implants | Polymer coatings | Polymers | Cardiology | Stents | Myocardial infarction | Embedding | Drug delivery | Biomedical materials | Randomization | Biocompatibility | Safety | Lesions | Thromboembolism | Complications | Blood vessels | Acute coronary syndromes | Index Medicus | Abridged Index Medicus | Life Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Long-term tolerability of ticagrelor for the secondary prevention of major adverse cardiovascular events: A secondary analysis of the PEGASUS-TIMI 54 trial
by Bonaca, Marc P and Bhatt, Deepak L and Oude Ophuis, Ton and Gabriel Steg, P and Storey, Robert and Cohen, Marc and Kuder, Julia and Im, Kyungah and Magnani, Giulia and Budaj, Andrzej and Theroux, Pierre and Hamm, Christian and Špinar, Jindřich and Kiss, Robert G and Dalby, Anthony J and Medina, Felix A and Kontny, Frederic and Aylward, Philip E and Jensen, Eva C and Held, Peter and Braunwald, Eugene and Sabatine, Marc S
JAMA cardiology, ISSN 2380-6583, 07/2016, Volume 1, Issue 4, pp. 425 - 432
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Dyspnea - chemically induced | Stroke - prevention & control | Adenosine - adverse effects | Adenosine - analogs & derivatives | Adenosine - therapeutic use | Humans | Purinergic P2Y Receptor Antagonists | Quality of Life | Myocardial Infarction - prevention & control | Secondary Prevention | Hemorrhage - chemically induced | Ticagrelor
Journal Article
Details down arrow
6. Full Text Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54
by Dellborg, Mikael and Bonaca, Marc P and Storey, Robert F and Steg, P Gabriel and Im, Kyung A and Cohen, Marc and Bhatt, Deepak L and Oude Ophuis, Ton and Budaj, Andrezej and Hamm, Christian and Spinar, Jindrich and Kiss, Robert G and Lopez-Sendon, José and Kamensky, Gabriel and Van de Werf, Frans and Ardissino, Diego and Kontny, Frederic and Montalescot, Gilles and Johanson, Per and Bengtsson, Olof and Himmelmann, Anders and Braunwald, Eugene and Sabatine, Marc S and Sahlgrenska akademin and Institute of Medicine and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy and Institutionen för medicin and Institute of Medicine, Department of Molecular and Clinical Medicine and Institutionen för medicin, avdelningen för molekylär och klinisk medicin
European heart journal. Cardiovascular pharmacotherapy, ISSN 2055-6837, 10/2019, Volume 5, Issue 4, pp. 200 - 206
Coronary artery disease | Post-myocardial infarction | Dual antiplatelet treatment | Cardiac & Cardiovascular Systems | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Recurrence | Myocardial Infarction - mortality | Purinergic P2Y Receptor Antagonists - administration & dosage | Humans | Middle Aged | Hemorrhage - mortality | Male | Drug Approval | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Ticagrelor - adverse effects | Time Factors | Platelet Aggregation Inhibitors - administration & dosage | Ticagrelor - administration & dosage | Female | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Myocardial Infarction - diagnosis | Risk Assessment | Europe | Risk Factors | Treatment Outcome | Randomized Controlled Trials as Topic | Drug Labeling | Myocardial Infarction - drug therapy | Aged | Hemorrhage - chemically induced | Stroke | Heart attacks | Mortality | Coronary vessels | Adenosine diphosphate | Clinical trials | Cardiovascular disease | Cardiology | Index Medicus | Life Sciences | Original | Kardiologi | Post-myocardial | Cardiac and Cardiovascular Systems | infarction | aspirin | risk | prevention | events | Klinisk medicin | Clinical Medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI
by Hohnloser, Stefan H and Steg, Philippe Gabriel and Oldgren, Jonas and Nickenig, Georg and Kiss, Robert G and Ongen, Zeki and Navarro Estrada, Jose L and Oude Ophuis, Ton and Lip, Gregory Y.H and Nordaby, Matias and Kleine, Eva and ten Berg, Jurrien M and Bhatt, Deepak L and Cannon, Christopher P and RE-DUAL PCI Steering Committee and Investigators and RE-DUAL PCI Steering Comm
JACC. Cardiovascular interventions, ISSN 1936-8798, 08/2019, Volume 12, Issue 16, pp. 1553 - 1561
warfarin triple therapy | renal function | atrial fibrillation | dabigatran dual therapy | percutaneous coronary intervention | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54
by Bonaca, Marc P and Bhatt, Deepak L and Steg, P. Gabriel and Storey, Robert F and Cohen, Marc and Im, Kyungah and Oude Ophuis, Ton and Budaj, Andrej and Goto, Shinya and López-Sendón, José and Diaz, Rafael and Dalby, Anthony and Van De Werf, Frans and Ardissino, Diego and Montalescot, Gilles and Aylward, Philip and Magnani, Giulia and Jensen, Eva C and Held, Peter and Braunwald, Eugene and Sabatine, Marc S
European heart journal, ISSN 0195-668X, 04/2016, Volume 37, Issue 14, pp. 1133 - 1142
Antiplatelet therapy | Secondary prevention | P2Y12 inhibition | Ischaemic risk | Platelet inhibition | Ticagrelor | Coronary artery disease | Myocardial Infarction - mortality | Purinergic P2Y Receptor Antagonists - administration & dosage | Drug Administration Schedule | Humans | Middle Aged | Risk Factors | Myocardial Ischemia - prevention & control | Male | Treatment Outcome | Secondary Prevention | Adenosine - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Myocardial Infarction - drug therapy | Adenosine - adverse effects | Adenosine - analogs & derivatives | Female | Aged | Myocardial Ischemia - mortality | Hemorrhage - chemically induced | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein A-I [human]), an intravenous formulation of plasma-derived apolipoprotein A-I, among subjects with moderate renal impairment after acute myocardial infarction
by Gibson, C. Michael and Kerneis, Mathieu and Yee, Megan K and Daaboul, Yazan and Korjian, Serge and Mehr, Ali Poyan and Tricoci, Pierluigi and Alexander, John H and Kastelein, John J.P and Mehran, Roxana and Bode, Christoph and Lewis, Basil S and Mehta, Ravindra and Duffy, Danielle and Feaster, John and Halabi, Majdi and Angiolillo, Dominick J and Duerschmied, Daniel and Ophuis, Ton Oude and Merkely, Bela
The American heart journal, ISSN 0002-8703, 02/2019, Volume 208, pp. 81 - 90
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Chronic kidney failure | Apolipoproteins | Heart attack | Myocardial infarction | Intravenous administration | Renal function | Heart attacks | Cardiovascular disease | Family medical history | Apolipoprotein A | Randomization | Ischemia | Population | Safety | Drug dosages | Creatinine | Efflux | Kidneys | Medical imaging | Diabetes mellitus | Health risks | Disease control | Patients | Cholesterol | Glomerular filtration rate | Coronary vessels | Apolipoprotein A-I | Infarction | Diabetes | Kidney diseases | Cardiovascular diseases | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text EDOXABAN VERSUS WARFARIN IN 841 PATIENTS WITH ATRIAL FIBRILLATION AND PERIPHERAL ARTERIAL DISEASE: INSIGHTS FROM THE ENGAGE AF-TIMI 48 TRIAL
by Cunningham, Jonathan and Giugliano, Robert and Braunwald, Eugene and Trevisan, Marco and Nordio, Francesco and Ophuis, Ton Oude and Bergovec, Mijo and Mercuri, Michele and Ruff, Christian and Bonaca, Marc
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2016, Volume 67, Issue 13, pp. 2262 - 2262
Cardiac arrhythmia | Stroke
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text EFFICACY AND SAFETY OF TICAGRELOR FOR LONG-TERM SECONDARY PREVENTION OF ATHEROTHROMBOTIC EVENTS IN PATIENTS WITH PRIOR MI AND MULTIVESSEL CORONARY DISEASE: INSIGHTS FROM THE PEGASUS-TIMI 54 TRIAL
by Bansilal, Sameer and Bonaca, Marc and Cornel, J.H and Storey, Robert and Bhatt, Deepak and Steg, Philippe and Im, Kelly and Held, Peter and Jensen, Eva and Braunwald, Eugene and Sabatine, Marc and Ophuis, Ton Oude
Journal of the American College of Cardiology, ISSN 0735-1097, 04/2016, Volume 67, Issue 13, pp. 2146 - 2146
Heart attacks
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text DOES RENAL FUNCTION INFLUENCE THE BENEFIT OF DUAL ANTITHROMBOTIC THERAPY WITH DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION? RESULTS FROM RE-DUAL PCI
by Hohnloser, Stefan and Steg, Philippe and Oldgren, Jonas and Nickenig, Georg and Kiss, Robert Gabor and Ongen, Zeki and Estrada, Jose Navarro and Ophuis, Ton Oude and Lip, Gregory and Nordaby, Matias and Kleine, Eva and Berg, Jurrien Ten and Bhatt, Deepak and Cannon, Christopher
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2018, Volume 71, Issue 11, pp. A314 - A314
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text A multi-site coronary sampling study on CRP in non-STEMI: Novel insights into the inflammatory process in acute coronary syndromes
by Damen, Sander A. J and Cramer, Gilbert E and Dieker, Henik-Jan and Gehlmann, Helmut and Aengevaeren, Wim R. M and Ophuis, Ton J. M. Oude and Fokkert, Marion J and Dikkeschei, Lambert D and Vroemen, Wim H. M and Verheugt, Freek W. A and Brouwer, Marc A and Suryapranata, Harry
Atherosclerosis, ISSN 0021-9150, 2018, Volume 278, pp. 117 - 123
NSTEMI | SOLUBLE CD40 LIGAND | COMPLEMENT | C-reactive protein | CIRCULATION | ATHEROSCLEROSIS | Inflammation | INTERLEUKIN-6 | PLAQUE | Coronary sinus | HEART | LEFT-VENTRICULAR DYSFUNCTION | ACUTE MYOCARDIAL-INFARCTION
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text A sirolimus-eluting bioabsorbable polymer-coated stent after percutaneous coronary intervention : a randomised, single-blind, multicentre, non-inferiority, phase 3 trial
by de Winter, Robbert J and Katagiri, Yuki and Asano, Taku and Milewski, Krzysztof P and Lurz, Philipp and Buszman, Pawel and Jessurun, Gillian A J and Koch, Karel T and Troquay, Roland P T and Hamer, Bas J B and Ophuis, Ton Oude and Wohrle, Jochen and Wyderka, Rafal and Cayla, Guillaume and Hofma, Sjoerd H and Levesque, Sebastien and Zurakowski, Aleksander and Fischer, Dieter and Kosmider, Maciej and Goube, Pascal and Arkenbout, E Karin and Noutsias, Michel and Ferrari, Markus W and Onuma, Yoshinobu and Wijns, William and Serruys, Patrick W
The Lancet (British edition), ISSN 0140-6736, 02/2018, Volume 391, Issue 10119, p. 431
Transluminal angioplasty | Product development | Polymer industry | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Vorapaxar in Patients With Diabetes Mellitus and Previous Myocardial Infarction: Findings From the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events-TIMI 50 Trial
by Cavender, Matthew A and Scirica, Benjamin M and Bonaca, Marc P and Angiolillo, Dominick J and Dalby, Anthony J and Dellborg, Mikael and Morais, Joao and Murphy, Sabina A and Ophuis, Ton Oude and Tendera, Michal and Braunwald, Eugene and Morrow, David A and Sahlgrenska akademin and Institute of Medicine and Göteborgs universitet and Gothenburg University and Sahlgrenska Academy and